Wädenswil/Zurich, Switzerland - Creoptix AG has joined forces with Suzhou Oeta Instrument Technology Co., Ltd and Bio-Gene Technology Ltd as channel partners for market expansion in China, Hong Kong and Macau. Collaboration with these two new partners supports Creoptix in our mission of enabling life scientists to accelerate discovery by providing cutting-edge tools for molecular interaction analysis.
“I’m impressed by our two new partners’ commitment to customers and passion for our WAVE technology, and look forward to a long-term and fruitful partnership over the coming years,” says Line Stigen Raquet, Creoptix CEO.
Suzhou Oeta is a sales and service company specializing in end-to-end laboratory solutions. “We are very pleased to introduce the Creoptix WAVE system into Chinese market and help Chinese scientists accelerate drug discovery. With its modern label-free technology, the WAVEsystem offers real-time insights into biological interactions, exceptional accuracy and efficiency,” says Xiujun Huang, owner of Suzhou Oeta Instruments.
Bio-Gene is a global leader in the distribution of world renowned instruments and reagents for life sciences research, clinical diagnostics and related industries. “Bio-Gene is excited to collaborate with Creotpix. We have been in the drug screening market for many years with our high-throughput plate readers and have the professional knowledge, technical support, and solutions to make the Creoptix WAVE system a good fit in China. The WAVEsystem complements and expands our product portfolio and provides complete solutions to our existing customers in pharmaceutical companies and CROs,” says P.S Liu, Bio-Gene General Manager.
Suzhoe Oeta and Bio-Gene will be responsible for all sales, marketing, service and support in China, Hong Kong and Macau.
